EMT in cancer

Similar to embryonic development, changes in cell phenotypes defined as an epithelial to mesenchymal transition (EMT) have been shown to play a role in the tumorigenic process. Although the first description of EMT in cancer was in cell cultures, evidence for its role in vivo is now widely reported but also actively debated. Moreover, current research has exemplified just how complex this phenomenon is in cancer, leaving many exciting, open questions for researchers to answer in the future. With these points in mind, we asked four scientists for their opinions on the role of EMT in cancer and the challenges faced by scientists working in this fast-moving field.

[1]  G. Longmore,et al.  Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. , 2014, Cancer research.

[2]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Baguley,et al.  Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines , 2013, Front. Genet..

[4]  Douglas S. Darling,et al.  Zeb1 links epithelial-mesenchymal transition and cellular senescence , 2008, Development.

[5]  Takuya Kato,et al.  A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion , 2017, Nature Cell Biology.

[6]  R. Fleischmajer.  Epithelial-mesenchymal interactions. , 1967, Science.

[7]  Anne E Carpenter,et al.  The Spemann organizer gene, Goosecoid, promotes tumor metastasis , 2006, Proceedings of the National Academy of Sciences.

[8]  E. Carver,et al.  The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition , 2001, Molecular and Cellular Biology.

[9]  Real-Time Imaging of the Epithelial-Mesenchymal Transition Using microRNA-200a Sequence-Based Molecular Beacon-Conjugated Magnetic Nanoparticles , 2014, PloS one.

[10]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[11]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[12]  R. Hruban,et al.  Human Correlates of Provocative Questions in Pancreatic Pathology , 2012, Advances in anatomic pathology.

[13]  Massimo Cristofanilli,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013 .

[14]  George Poste,et al.  The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.

[15]  Mikala Egeblad,et al.  Caught in the act: revealing the metastatic process by live imaging , 2013, Disease Models & Mechanisms.

[16]  H. Mehdorn,et al.  Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas. , 2015, International journal of oncology.

[17]  Robert A. Weinberg,et al.  Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity , 2013, Cell.

[18]  M. Nieto.  Context-specific roles of EMT programmes in cancer cell dissemination , 2017, Nature Cell Biology.

[19]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[20]  A. Moon,et al.  Epithelial-mesenchymal Transition and Cell Invasion , 2010, Toxicological research.

[21]  Hong Wu,et al.  Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. , 2015, Cancer research.

[22]  Eliah R. Shamir,et al.  Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration. , 2015, Current topics in developmental biology.

[23]  Bruce G. Haffty,et al.  Elf5 inhibits epithelial mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2/Slug , 2012, Nature Cell Biology.

[24]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[25]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[26]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.

[27]  Genevieve Housman,et al.  EMT and tumor metastasis , 2015, Clinical and Translational Medicine.

[28]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[29]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[30]  Maryam K. Mohammed,et al.  Transition to resistance: An unexpected role of the EMT in cancer chemoresistance , 2016, Genes & diseases.

[31]  C. Pilarsky,et al.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.

[32]  M. Nieto,et al.  The Snail genes as inducers of cell movement and survival: implications in development and cancer , 2005, Development.

[33]  M. Falasca,et al.  Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer , 2017, World journal of gastrointestinal oncology.

[34]  F. Kruyt,et al.  EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities , 2017, Molecular oncology.

[35]  T. Brabletz.  To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.

[36]  X. Liu,et al.  Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer , 2016, Nature Cell Biology.

[37]  A. E. Sayan,et al.  Tumour-promoting role of EMT-inducing transcription factor ZEB1 in mantle cell lymphoma , 2014, Cell Death and Differentiation.

[38]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[39]  Wen Bu,et al.  Breast tumor cell-specific knockout of Twist1 inhibits cancer cell plasticity, dissemination, and lung metastasis in mice , 2017, Proceedings of the National Academy of Sciences.

[40]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[41]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[42]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[43]  Andrew J. Ewald,et al.  A collective route to metastasis: Seeding by tumor cell clusters , 2016, Science.

[44]  Simone Brabletz,et al.  The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer? , 2010, EMBO reports.

[45]  Jing Yang,et al.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.

[46]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[47]  R. Weinberg,et al.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells , 2015, Nature.

[48]  A. Puisieux,et al.  Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.

[49]  Huamin Wang,et al.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.

[50]  G. Berx,et al.  Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression , 2014, Cell Death and Differentiation.

[51]  Florence March,et al.  2016 , 2016, Affair of the Heart.

[52]  A. van Oudenaarden,et al.  Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity , 2016, Cell reports.

[53]  M. Kyba,et al.  MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome. , 2016, Cancer cell.

[54]  I. Malanchi,et al.  The EMT universe: space between cancer cell dissemination and metastasis initiation. , 2014, Critical reviews in oncogenesis.

[55]  G. Berx,et al.  Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity. , 2017, Trends in genetics : TIG.

[56]  R. Weinberg,et al.  Upholding a role for EMT in breast cancer metastasis , 2017, Nature.

[57]  R. Weinberg,et al.  Upholding a role for EMT in pancreatic cancer metastasis , 2017, Nature.

[58]  R. Weinberg,et al.  EMT, cell plasticity and metastasis , 2016, Cancer and Metastasis Reviews.

[59]  Andrew J. Ewald,et al.  Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program , 2013, Cell.

[60]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[61]  Huiguang Yang,et al.  Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma , 2012, Journal of surgical oncology.